Hyun C. Chung, MD, PhD, professor at Yonsei Cancer Center, Yonsei University College of Medicine in Seoul, Republic of Korea, discusses the rationale of the KEYNOTE-811 study in HER2-positive gastric cancer. Website:
Twitter:
Facebook:
LinkedIn:
Dr. Chung on the Rationale of the KEYNOTE-811 Trial in HER2+ Gastric Cancer
Hyun C. Chung, MD, PhD, professor at Yonsei Cancer Center, Yonsei University College of Medicine in Seoul, Republic of Korea, discusses the rationale of the KEYNOTE-811 study in HER2-positive gastric cancer. Website:
Twitter:
Facebook:
LinkedIn:
![Devoted: Stir Up Your Spirit Faith [1 Samuel 30:10]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sZ23eb7ynQx9ZctdoFaPOBeqcVhrHYdNUFVdcco0wOHHszgMfRBAF1k9Xkp0iPYXfnZScrIOaJx0_dd8chp_TMr7u_zlNYXsc1RWIOhJAMgPImDw=w680)
0 Comments